Editor's Note The US Food and Drug administration approved Zevtera for treating Staphylococcus aureus bacteremia (SAB) bloodstream infections, which are often acquired in healthcare settings. In the April 3 announcement, the agency notes the new antibiotic Zevtera (ceftobiprole medocaril sodium for injection) is effective for SAB-infected patients with right-sided infective…
Editor's Note Recent research delved into the connection between the transmission of antibiotic-resistant bacteria in the anesthesia work area and the occurrence of surgical site infections (SSIs), Anesthesiology News July 19 reports. While it was previously recognized that reducing microbial transmission through the anesthesia work area is crucial for preventing…